![EP0551848B1 - Ophthalmic pharmaceutical composition containing N- acetyl-cysteine and polyvinylalcohol - Google Patents EP0551848B1 - Ophthalmic pharmaceutical composition containing N- acetyl-cysteine and polyvinylalcohol - Google Patents](https://patentimages.storage.googleapis.com/44/c2/d7/ff8d93e46edafa/00120001.png)
EP0551848B1 - Ophthalmic pharmaceutical composition containing N- acetyl-cysteine and polyvinylalcohol - Google Patents
![Pharmaceuticals | Free Full-Text | Stability Study of Parenteral N- Acetylcysteine, and Chemical Inhibition of Its Dimerization Pharmaceuticals | Free Full-Text | Stability Study of Parenteral N- Acetylcysteine, and Chemical Inhibition of Its Dimerization](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00072/article_deploy/html/images/pharmaceuticals-16-00072-g001.png)
Pharmaceuticals | Free Full-Text | Stability Study of Parenteral N- Acetylcysteine, and Chemical Inhibition of Its Dimerization
![Patients with ripe cataract further improve vision with combination of Can-C Eye Drops and Nac-C Plus Capsules - Wise Choice Medicine Patients with ripe cataract further improve vision with combination of Can-C Eye Drops and Nac-C Plus Capsules - Wise Choice Medicine](https://www.wisechoicemedicine.com/wp-content/uploads/Can-CNAC-C-1-550x445.jpg)
Patients with ripe cataract further improve vision with combination of Can-C Eye Drops and Nac-C Plus Capsules - Wise Choice Medicine
![PDF) Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology PDF) Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology](https://i1.rgstatic.net/publication/323807758_Early_results_on_the_use_of_chitosan-N-acetylcysteine_LacrimeraR_in_the_management_of_dry_eye_disease_of_varied_etiology/links/5fbe0c2a299bf104cf74c744/largepreview.png)